{ "@context": "https://agentflare.org/schema", "type": "Corporation", "tier": "L2-full", "title": "Eli Lilly & Co (LLY) Stock Price, Chart, Fundamentals & News", "description": "Eli Lilly shares trade at $1,252.00 after a 25.7% six-month gain, with a P/E of 41.87 against a tracked peer median of 29.40. Recent headlines cover a proposed shareholder share sale and pipeline developments.", "canonical": "https://agentflare.org/markets/lly.html", "category": "markets", "updated": "2026-10-16", "generated_at": "2026-10-16T00:37:01.652Z", "facts": [ { "label": "Ticker", "value": "LLY" }, { "label": "Exchange", "value": "NYSE" }, { "label": "Sector", "value": "Health Care" }, { "label": "Industry", "value": "Pharmaceuticals" }, { "label": "HQ", "value": "Indiana; U.S.A" } ], "data": { "ticker": "LLY", "name": "Eli Lilly & Co", "generated_at": "2026-10-16T00:37:01.652Z", "price_usd": 1252, "day_change_pct": 3.58, "returns_pct": { "m1": -0.8770280204468903, "m3": 3.0508233579496413, "m6": 25.701897018970183 }, "metrics": { "ticker": "LLY", "currency": "USD", "market_cap": 1177920095434.75, "enterprise_value": 1223878095434.75, "price_to_book_ratio": 34.76844344386641, "price_to_earnings_ratio": 41.865839423163315, "price_to_sales_ratio": 14.785768741853468, "enterprise_value_to_ebitda_ratio": 34.25198131163312, "enterprise_value_to_revenue_ratio": 15.362653678677049, "free_cash_flow_yield": 0.015442558515216047, "peg_ratio": 0.44124119226611996, "gross_margin": 0.8339940099766776, "operating_margin": 0.42217488558452937, "net_margin": 0.33529067680234176, "return_on_equity": 0.7884294105493078, "return_on_assets": 0.18773289851914846, "return_on_invested_capital": 0.3328029735586257, "asset_turnover": 0.6155150101020247, "inventory_turnover": 5.086891003128791, "receivables_turnover": 4.137193601994183, "days_sales_outstanding": 88.22405599391458, "operating_cycle": 159.97711690587428, "working_capital_turnover": 3.3105113341228782, "current_ratio": 1.3546427598919168, "quick_ratio": 1.0028905971806203, "cash_ratio": 0.18746988961270186, "operating_cash_flow_ratio": 0.5882469994344484, "debt_to_equity": 1.6207089937719532, "debt_to_assets": 0.3859069600725315, "interest_coverage": null, "revenue_growth": 0.49584382469521066, "earnings_growth": 0.935608229045138, "book_value_growth": 0.8540571009527771, "earnings_per_share_growth": 0.9488198327121129, "free_cash_flow_growth": 2.723740506458679, "operating_income_growth": 0.9511698467857496, "ebitda_growth": 0.8130505378526487, "payout_ratio": 0.21656458713947707, "earnings_per_share": 29.888329417030324, "book_value_per_share": 37.908694192682105, "free_cash_flow_per_share": 20.353698108985117 }, "company": { "ticker": "LLY", "name": "Eli Lilly & Co", "cik": "0000059478", "sector": "Health Care", "industry": "Pharmaceuticals", "exchange": "NYSE", "is_active": true, "location": "Indiana; U.S.A", "sec_filings_url": "https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000059478", "sic_code": "2834", "sic_industry": "Pharmaceutical Preparations", "sic_sector": "Manufacturing" }, "history": [ { "date": "2026-04-14", "close": 922.5, "volume": 2360236 }, { "date": "2026-04-15", "close": 905.03, "volume": 4233418 }, { "date": "2026-04-16", "close": 903.99, "volume": 2836574 }, { "date": "2026-04-17", "close": 927.03, "volume": 3266094 }, { "date": "2026-04-20", "close": 919.9, "volume": 1926259 }, { "date": "2026-04-21", "close": 903.02, "volume": 4062792 }, { "date": "2026-04-22", "close": 921.48, "volume": 2623775 }, { "date": "2026-04-23", "close": 917.65, "volume": 2149232 }, { "date": "2026-04-24", "close": 883.96, "volume": 4463678 }, { "date": "2026-04-27", "close": 868.27, "volume": 2700286 }, { "date": "2026-04-28", "close": 874, "volume": 2561280 }, { "date": "2026-04-29", "close": 851.21, "volume": 3904584 }, { "date": "2026-04-30", "close": 934.6, "volume": 8236718 }, { "date": "2026-05-01", "close": 963.33, "volume": 4352441 }, { "date": "2026-05-04", "close": 967.93, "volume": 3696945 }, { "date": "2026-05-05", "close": 988.87, "volume": 2955528 }, { "date": "2026-05-06", "close": 987.05, "volume": 3921221 }, { "date": "2026-05-07", "close": 974.96, "volume": 3494856 }, { "date": "2026-05-08", "close": 948.45, "volume": 3559161 }, { "date": "2026-05-11", "close": 966.99, "volume": 3517454 }, { "date": "2026-05-12", "close": 989.87, "volume": 3037467 }, { "date": "2026-05-13", "close": 1015.75, "volume": 3486425 }, { "date": "2026-05-14", "close": 1006.7, "volume": 1751682 }, { "date": "2026-05-15", "close": 1004.92, "volume": 2820726 }, { "date": "2026-05-18", "close": 988.09, "volume": 2015971 }, { "date": "2026-05-19", "close": 1021.41, "volume": 3796015 }, { "date": "2026-05-20", "close": 1018.87, "volume": 2998810 }, { "date": "2026-05-21", "close": 1041.65, "volume": 2705204 }, { "date": "2026-05-22", "close": 1065, "volume": 3472924 }, { "date": "2026-05-26", "close": 1064.74, "volume": 2983414 }, { "date": "2026-05-27", "close": 1082.92, "volume": 2587481 }, { "date": "2026-05-28", "close": 1126.8, "volume": 4605822 }, { "date": "2026-05-29", "close": 1105, "volume": 4603028 }, { "date": "2026-06-01", "close": 1082.2, "volume": 2693447 }, { "date": "2026-06-02", "close": 1064.15, "volume": 2408537 }, { "date": "2026-06-03", "close": 1078.78, "volume": 2655644 }, { "date": "2026-06-04", "close": 1125.27, "volume": 4046733 }, { "date": "2026-06-05", "close": 1131.42, "volume": 4126160 }, { "date": "2026-06-08", "close": 1149.15, "volume": 4504437 }, { "date": "2026-06-09", "close": 1144.68, "volume": 3822027 }, { "date": "2026-06-10", "close": 1136.37, "volume": 2700635 }, { "date": "2026-06-11", "close": 1160.95, "volume": 2764934 }, { "date": "2026-06-12", "close": 1133, "volume": 2438390 }, { "date": "2026-06-15", "close": 1129.35, "volume": 3167157 }, { "date": "2026-06-16", "close": 1122.5, "volume": 2260747 }, { "date": "2026-06-17", "close": 1112, "volume": 2383254 }, { "date": "2026-06-18", "close": 1098.57, "volume": 4470535 }, { "date": "2026-06-22", "close": 1102.08, "volume": 3015040 }, { "date": "2026-06-23", "close": 1107.08, "volume": 3316278 }, { "date": "2026-06-24", "close": 1117.26, "volume": 2908248 }, { "date": "2026-06-25", "close": 1127.69, "volume": 2760164 }, { "date": "2026-06-26", "close": 1208.12, "volume": 7725847 }, { "date": "2026-06-29", "close": 1229.93, "volume": 3684723 }, { "date": "2026-06-30", "close": 1199.43, "volume": 3723583 }, { "date": "2026-07-01", "close": 1191.74, "volume": 2720449 }, { "date": "2026-07-02", "close": 1213.91, "volume": 3297441 }, { "date": "2026-07-06", "close": 1200.06, "volume": 2348798 }, { "date": "2026-07-07", "close": 1235.56, "volume": 2933770 }, { "date": "2026-07-08", "close": 1215.83, "volume": 2608556 }, { "date": "2026-07-09", "close": 1216.95, "volume": 2088071 }, { "date": "2026-07-10", "close": 1188.58, "volume": 2010190 }, { "date": "2026-07-13", "close": 1181.87, "volume": 2072666 }, { "date": "2026-07-14", "close": 1152.54, "volume": 2642940 }, { "date": "2026-07-15", "close": 1156.63, "volume": 2552230 }, { "date": "2026-07-16", "close": 1169.17, "volume": 2791060 }, { "date": "2026-07-17", "close": 1179.11, "volume": 2757541 }, { "date": "2026-07-20", "close": 1146.9, "volume": 2644242 }, { "date": "2026-07-21", "close": 1175.41, "volume": 2092000 }, { "date": "2026-07-22", "close": 1163.01, "volume": 1555768 }, { "date": "2026-07-23", "close": 1185.87, "volume": 1909944 }, { "date": "2026-07-24", "close": 1196.03, "volume": 1983288 }, { "date": "2026-07-27", "close": 1197.53, "volume": 1593652 }, { "date": "2026-07-28", "close": 1220.66, "volume": 2379981 }, { "date": "2026-07-29", "close": 1210.02, "volume": 2173483 }, { "date": "2026-07-30", "close": 1154.97, "volume": 3030710 }, { "date": "2026-07-31", "close": 1148.84, "volume": 2884613 }, { "date": "2026-08-03", "close": 1121.36, "volume": 2934021 }, { "date": "2026-08-04", "close": 1115.68, "volume": 4097186 }, { "date": "2026-08-05", "close": 1169.86, "volume": 6445689 }, { "date": "2026-08-06", "close": 1191.94, "volume": 3422379 }, { "date": "2026-08-07", "close": 1185.71, "volume": 2898528 }, { "date": "2026-08-10", "close": 1231.94, "volume": 3011882 }, { "date": "2026-08-11", "close": 1215.02, "volume": 2113241 }, { "date": "2026-08-12", "close": 1220.28, "volume": 1941576 }, { "date": "2026-08-13", "close": 1209, "volume": 1927272 }, { "date": "2026-08-14", "close": 1180.16, "volume": 2274505 }, { "date": "2026-08-17", "close": 1183.16, "volume": 1807037 }, { "date": "2026-08-18", "close": 1225.73, "volume": 2509057 }, { "date": "2026-08-19", "close": 1280.34, "volume": 4541762 }, { "date": "2026-08-20", "close": 1244.4, "volume": 2621394 }, { "date": "2026-08-21", "close": 1255.4, "volume": 2503262 }, { "date": "2026-08-24", "close": 1246.93, "volume": 1665577 }, { "date": "2026-08-25", "close": 1233.66, "volume": 2143184 }, { "date": "2026-08-26", "close": 1189.41, "volume": 3006472 }, { "date": "2026-08-27", "close": 1176.1, "volume": 2735051 }, { "date": "2026-08-28", "close": 1174.61, "volume": 2451810 }, { "date": "2026-08-31", "close": 1156.73, "volume": 3057885 }, { "date": "2026-09-01", "close": 1160, "volume": 2522522 }, { "date": "2026-09-02", "close": 1160.08, "volume": 2446970 }, { "date": "2026-09-03", "close": 1159.6, "volume": 2553292 } ], "peers": [ "UNH", "JNJ" ], "analysis": [ { "h": "What the company does", "body": "Eli Lilly and Co operates in the pharmaceuticals industry within the Health Care sector. The company is based in Indiana, U.S.A., and its shares trade on the NYSE under the ticker LLY. With a market capitalization of $1.18T, it is a large listed company in its sector. Reported profitability includes a gross margin of 83.4%, an operating margin of 42.2% and a net margin of 33.5%. The company also reports a debt-to-equity ratio of 1.62, which investors often weigh alongside its growth and pipeline." }, { "h": "Price action and valuation versus peers", "body": "Shares last traded at $1,252.00, up 3.58% on the day. Over roughly one month the stock is down 0.9%, while it is up 3.1% over roughly three months and up 25.7% over roughly six months. Its six-month high is $1,280.34, reached on 2026-08-19, and its low is $851.21, reached on 2026-04-29. Against tracked Health Care peers, the P/E of 41.87 compares with a peer median P/E of 29.40 across UNH and JNJ. The PEG ratio is 0.44, with P/S at 14.79, P/B at 34.77 and EV/EBITDA at 34.25. Latest year-over-year revenue grew 49.6% and earnings grew 93.6%." }, { "h": "What the recent headlines say", "body": "Stock Titan reported that shareholder Lilly Endowment has proposed a sale of 305,000 shares. GuruFocus said a GF Score of 96 signals strong outperformance potential for the stock. Benzinga published an article on how much an investor would have made owning the stock over the last 20 years. StocksToTrade linked the stock's move higher to a deepening obesity and diabetes pipeline. ETF Database covered a new peptide ETF from REX that looks beyond GLP-1 drugs. Moomoo also published a stock note on the company." } ], "faq": [ { "q": "What does Eli Lilly do?", "a": "Eli Lilly and Co operates in the pharmaceuticals industry within the Health Care sector. It is based in Indiana, U.S.A., and trades on the NYSE under the ticker LLY, with a market capitalization of $1.18T." }, { "q": "How does Eli Lilly's valuation compare with peers?", "a": "Its P/E is 41.87, compared with a tracked Health Care peer median P/E of 29.40 across UNH and JNJ. Its PEG ratio is 0.44, P/S is 14.79 and EV/EBITDA is 34.25." }, { "q": "What does the proposed share sale headline mean?", "a": "Stock Titan reported that shareholder Lilly Endowment has proposed selling 305,000 shares. The headline describes a proposal only and does not indicate how or when any sale would occur." } ], "newswire": [ { "date": "2026-10-15", "title": "Eli Lilly climbs about 4.0% on obesity and diabetes data", "href": "/news/2026-10-15-markets.html", "desk": "markets" } ] }, "analysis_md": "Eli Lilly shares trade at $1,252.00 after a 25.7% six-month gain, with a P/E of 41.87 against a tracked peer median of 29.40. Recent headlines cover a proposed shareholder share sale and pipeline developments.\n\n## What the company does\n\nEli Lilly and Co operates in the pharmaceuticals industry within the Health Care sector. The company is based in Indiana, U.S.A., and its shares trade on the NYSE under the ticker LLY. With a market capitalization of $1.18T, it is a large listed company in its sector. Reported profitability includes a gross margin of 83.4%, an operating margin of 42.2% and a net margin of 33.5%. The company also reports a debt-to-equity ratio of 1.62, which investors often weigh alongside its growth and pipeline.\n\n## Price action and valuation versus peers\n\nShares last traded at $1,252.00, up 3.58% on the day. Over roughly one month the stock is down 0.9%, while it is up 3.1% over roughly three months and up 25.7% over roughly six months. Its six-month high is $1,280.34, reached on 2026-08-19, and its low is $851.21, reached on 2026-04-29. Against tracked Health Care peers, the P/E of 41.87 compares with a peer median P/E of 29.40 across UNH and JNJ. The PEG ratio is 0.44, with P/S at 14.79, P/B at 34.77 and EV/EBITDA at 34.25. Latest year-over-year revenue grew 49.6% and earnings grew 93.6%.\n\n## What the recent headlines say\n\nStock Titan reported that shareholder Lilly Endowment has proposed a sale of 305,000 shares. GuruFocus said a GF Score of 96 signals strong outperformance potential for the stock. Benzinga published an article on how much an investor would have made owning the stock over the last 20 years. StocksToTrade linked the stock's move higher to a deepening obesity and diabetes pipeline. ETF Database covered a new peptide ETF from REX that looks beyond GLP-1 drugs. Moomoo also published a stock note on the company.\n\n## Fundamentals\n\n- Market cap: $1.18T\n- Enterprise value: $1.22T\n- P/E: 41.87\n- P/S: 14.79\n- P/B: 34.77\n- EV/EBITDA: 34.25\n- PEG: 0.44\n- EPS: $29.89\n- Debt/equity: 1.62\n- Current ratio: 1.35\n- FCF yield: 1.5%\n- Payout ratio: 21.7%\n\n## Recent headlines\n\n- [A 305,000-share sale is proposed by Eli Lilly (LLY) shareholder Lilly Endowment. - Stock Titan](https://www.stocktitan.net/sec-filings/LLY/144-eli-lilly-co-sec-filing-b358eddb7bed.html) — Stock Titan 2026-10-15\n- [Eli Lilly and Co (LLY): GF Score of 96 Signals Strong Outperformance Potential - GuruFocus](https://www.gurufocus.com/news/9125860/eli-lilly-and-co-lly-gf-score-of-96-signals-strong-outperformance-potential) — GuruFocus 2026-10-15\n- [$Eli Lilly and Co (LLY.US)$ - Moomoo](https://www.moomoo.com/community/feed/eli-lilly-and-co-lly-us-117445599756294) — Moomoo 2026-10-15\n- [Here’s How Much You Would Have Made Owning Eli Lilly Stock In The Last 20 Years - Benzinga](https://www.benzinga.com/news/26/10/62384758/here-s-how-much-you-would-have-made-owning-eli-lilly-stock-last-20-years) — Benzinga 2026-10-15\n- [LLY Stock Powers Higher As Obesity And Diabetes Pipeline Deepens - StocksToTrade](https://stockstotrade.com/news/eli-lilly-and-company-lly-news-2026_10_14/) — StocksToTrade 2026-10-14\n- [New Peptide ETF From REX Looks Beyond GLP-1 Drugs - ETF Database](https://etfdb.com/thematic-investing-content-hub/new-peptide-etf-from-rex-looks-beyond-glp-1-drugs/) — ETF Database 2026-10-14\n\n## FAQ\n\n**What does Eli Lilly do?**\nEli Lilly and Co operates in the pharmaceuticals industry within the Health Care sector. It is based in Indiana, U.S.A., and trades on the NYSE under the ticker LLY, with a market capitalization of $1.18T.\n\n**How does Eli Lilly's valuation compare with peers?**\nIts P/E is 41.87, compared with a tracked Health Care peer median P/E of 29.40 across UNH and JNJ. Its PEG ratio is 0.44, P/S is 14.79 and EV/EBITDA is 34.25.\n\n**What does the proposed share sale headline mean?**\nStock Titan reported that shareholder Lilly Endowment has proposed selling 305,000 shares. The headline describes a proposal only and does not indicate how or when any sale would occur.\n", "sources": [ { "title": "A 305,000-share sale is proposed by Eli Lilly (LLY) shareholder Lilly Endowment. - Stock Titan", "url": "https://www.stocktitan.net/sec-filings/LLY/144-eli-lilly-co-sec-filing-b358eddb7bed.html" }, { "title": "Eli Lilly and Co (LLY): GF Score of 96 Signals Strong Outperformance Potential - GuruFocus", "url": "https://www.gurufocus.com/news/9125860/eli-lilly-and-co-lly-gf-score-of-96-signals-strong-outperformance-potential" }, { "title": "$Eli Lilly and Co (LLY.US)$ - Moomoo", "url": "https://www.moomoo.com/community/feed/eli-lilly-and-co-lly-us-117445599756294" }, { "title": "Here’s How Much You Would Have Made Owning Eli Lilly Stock In The Last 20 Years - Benzinga", "url": "https://www.benzinga.com/news/26/10/62384758/here-s-how-much-you-would-have-made-owning-eli-lilly-stock-last-20-years" }, { "title": "LLY Stock Powers Higher As Obesity And Diabetes Pipeline Deepens - StocksToTrade", "url": "https://stockstotrade.com/news/eli-lilly-and-company-lly-news-2026_10_14/" }, { "title": "AISA Financial API", "url": "https://aisa.one/docs/api-reference/financial/getprices" }, { "title": "Eli Lilly & Co SEC filings", "url": "https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000059478" } ], "related": [ { "name": "Unitedhealth Group Inc (UNH)", "url": "https://agentflare.org/markets/unh.html" }, { "name": "Johnson & Johnson (JNJ)", "url": "https://agentflare.org/markets/jnj.html" }, { "name": "Apple Inc (AAPL)", "url": "https://agentflare.org/markets/aapl.html" }, { "name": "Microsoft Corp (MSFT)", "url": "https://agentflare.org/markets/msft.html" }, { "name": "Nvidia Corp (NVDA)", "url": "https://agentflare.org/markets/nvda.html" }, { "name": "Alphabet Inc (GOOGL)", "url": "https://agentflare.org/markets/googl.html" } ], "pricing": { "price_usd": 0.01, "method": "402", "endpoint": "https://esa.aisa.one/api/v1/access/verify", "autopay_hint": "set crawlerAutoPrice=true with the X-Crawler-Token header", "onboarding": "https://esa.aisa.one/agent/guide.html" }, "powered_by": "AISA — agent-native search, settlement & delivery (https://aisa.one)" }